valinor : Mensaje: todos conttra la injusticia

********
      Medicos Sin Fronteras pide la firma, entrando en la pagina Web que =
figura en el mensaje, para exigir que las 39 empresas farmaceuticas =
retiren el juicio por patentes que han iniciado contra Sudafrica por =
fabricar genericos baratos para combatir el SIDA. Por favor, tratad de =
dar la maxima difusion a este mensaje.

    En Sudafrica, uno de cada 5 adultos esta infectado con el VIH/SIDA. =
Actualmente son ya mas de 4 millones de personas las que sufren esta =
enfermedad. Mientras tanto, 39 empresas farmaceuticas han presentado una =
al Gobierno de Sudafrica en contra de las leyes que pretenden hacer mas =
asequibles y accesibles los medicamentos esenciales a su poblacion.=20

    El proximo 18 de Abril se celebrara el juicio. Por favor, AYUDANOS A =
FRENAR ESTA DEMANDA.ENTRA EN NUESTRA PAGINA WEB:   www.msf.es Y FIRMA LA =
PETICION DE PROTESTA en http://www.msf.es/4_1.asp ENVIA ESTE MENSAJE AL =
MAXIMO NUMERO DE PERSONAS POSIBLE

**********

    Sign the Drop the Case petition MSF will send your signature* to the =
39 pharmaceutical companies and to governments to send a clear message =
that protecting lives should come before protecting patents.=20

    *Only your name and country of residence will be sent to companies =
and governments. MSF will not release your email address publicly. The =
39 pharmaceutical companies in the South African court case webplaced:=20

    March 9, 2001

    A complete list of the 39 pharmaceutical companies suing the South =
African government to prevent the distribution of essential medications =
under South African law.

    - The Pharmaceutical Manufacturers' Association of South Africa=20

    - Alcon Laboratories (S.A.) (Proprietary) Limited

    - Bayer (Proprietary) Limited

    - Bristol-Myers Squibb (Proprietary) Limited

    - Byk Madaus (Proprietary) Limited

    - Eli Lilly (South Africa) (Proprietary) Limited

    - Glaxo Wellcome (South Africa) (Proprietary) Limited

    - Hoechst Marion Roussel Limited

    - Ingelheim Pharmaceuticals (Proprietary) Limited

    - Janssen-Cilag Pharmaceutica (Proprietary) Limited

    - Knoll Pharmaceuticals South Africa (Proprietary) Limited

    - Lundbeck South Africa (Proprietary) Limited

    - Merck (Proprietary) Limited

    - MSD (Proprietary) Limited

    - Novartis South Africa (Proprietary) Limited

    - Novo Nordisk (Proprietary) Limited

    - & Upjohn (Proprietary) Limited

    - Rhone-Poulenc Rorer South Africa (Proprietary) Limited

    - Roche Products (Proprietary) Limited

    - Schering (Proprietary) Limited

    - Schering-Plough (Proprietary) Limited

    - S.A. Scientific Pharmaceuticals (Proprietary) Limited

    - SmithKline Beecham Pharmaceuticals (Proprietary) Limited Universal

    - Pharmaceuticals (Proprietary) Limited

    - Wyeth (Proprietary) Limited

    - Xixia Pharmaceuticals (Proprietary) Limited

    - Zeneca South Africa (Proprietary) Limited

    - Bayer AG

    - Boehringer-Ingelheim International GmbH

    - Boehringer-Ingelheim KG

    - Bristol-Myers Squibb Company

    - Byk Gulden Lomberg Chemische Fabrik GmbH

    - Dr. Karl Thomae GmbH

    - Eli Lilly and Company

    - F. Hoffman-La Roche AG

    - Merck KGaA

    - & Co., Inc.

    - Rhone-Poulenc Rorer S.A.

--------------End of Original Message-----------------

Salvador Moreno Rivas.
C/Ponce de León Nº15.
Utrera (Sevilla). CP: 41710.
Tlf: 954860888.

Consejos de Yahoo! Grupos

¿Sabías que...?

Mensajes